|
Delayed
Bombay S.E.
03:08:17 2026-09-08 am EDT
|
5-day change | 1st Jan Change | ||
| 2,803.95 INR | -0.34% |
|
+3.57% | +52.50% |
| Aug. 14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| Aug. 12 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Company Valuation: Caplin Point Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 51,529 | 45,291 | 100,038 | 152,221 | 114,409 | 213,863 | - |
| Change | - | -12.11% | 120.88% | 52.16% | -24.84% | 86.93% | - |
| Enterprise Value (EV) | 51,529 | 45,291 | 100,038 | 152,221 | 114,409 | 213,863 | 213,863 |
| Change | - | -12.11% | 120.88% | 52.16% | -24.84% | 86.93% | 0% |
| P/E | 17.3x | 12.1x | 22x | 28.5x | 17.9x | 29.4x | 25.4x |
| PBR | 3.47x | 2.41x | 4.32x | 5.34x | 3.19x | 4.84x | 4.38x |
| PEG | - | 0.5x | 1x | 1.6x | 0.9x | 2.2x | 1.6x |
| Capitalization / Revenue | 4.06x | 3.09x | 5.91x | 7.86x | 5.23x | 8.53x | 7.55x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 8.53x | 7.55x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 24.6x | 21.3x |
| EV / EBIT | 0x | 0x | - | 0x | 0x | 22.9x | 19.9x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 38.5x | 37.9x |
| FCF Yield | 4.77% | 1.72% | 1.73% | 1.58% | 2.4% | 2.6% | 2.64% |
| Dividend per Share 2 | 2 | 2 | 2.5 | 3 | - | 4 | 4 |
| Rate of return | 0.29% | 0.34% | 0.19% | 0.15% | - | 0.14% | 0.14% |
| EPS 2 | 39.26 | 49.18 | 59.9 | 70.25 | 84.11 | 95.6 | 110.7 |
| Distribution rate | 5.09% | 4.07% | 4.17% | 4.27% | - | 4.18% | 3.61% |
| Net sales 1 | 12,694 | 14,667 | 16,941 | 19,375 | 21,872 | 25,072 | 28,340 |
| EBITDA 1 | 3,947 | 4,411 | 5,514 | 6,469 | 7,609 | 8,700 | 10,050 |
| EBIT 1 | 3,478 | 4,520 | - | 5,810 | 8,036 | 9,321 | 10,752 |
| Net income 1 | 2,998 | 3,763 | 4,571 | 5,363 | 6,412 | 7,264 | 8,411 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 679.90 | 596.70 | 1,317.30 | 2,002.60 | 1,505.15 | 2,813.55 | 2,813.55 |
| Nbr of stocks (in thousands) | 75,789 | 75,903 | 75,942 | 76,012 | 76,012 | 76,012 | - |
| Announcement Date | 5/12/22 | 5/27/23 | 5/16/24 | 5/15/25 | 5/14/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 29.43x | - | - | - | 2.26B | |
| 34.97x | 6.57x | 22.76x | 0.9% | 48.08B | |
| 16.83x | 2.08x | 9.26x | 1.53% | 39.95B | |
| 27.16x | 3.29x | 17.07x | 0.93% | 11.92B | |
| 27.74x | 3.96x | 16.4x | 0.58% | 12.2B | |
| 18.88x | 3.36x | 11.68x | 3.82% | 9.22B | |
| 9.31x | 2.14x | 5.53x | 4.65% | 7.41B | |
| 15.6x | 2.04x | 6.78x | 3.23% | 7.37B | |
| 29.82x | 3.9x | 18.16x | 0.16% | 7.32B | |
| Average | 23.30x | 3.42x | 13.45x | 1.98% | 16.19B | |
| Weighted average by Cap. | 25.10x | 4.02x | 15.33x | 1.52% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CAPLIPOINT Stock
- Valuation Caplin Point Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
